Clicky

RAPT Therapeutics, Inc.(RAPT) News

Date Title
Feb 20 FDA puts hold on Rapt trials of drug for eczema, asthma
Jan 2 RAPT Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Nov 27 RAPT Therapeutics Announces Publication of Phase 1a/1b Clinical Trial of Zelnecirnon (RPT193) to Treat Atopic Dermatitis in Allergy
Aug 8 This RAPT Therapeutics Insider Increased Their Holding By 22% Last Year